Document is current
Any future updates will be listed below
-
Authors
Balasubramanian, Adithya
Gunjur, Ashray
Weickhardt, Andrew
Papa, Nathan
Bolton, Damien
Lawrentschuk, Nathan
Perera, Marlon https://orcid.org/0000-0002-1138-6389
- License Information
-
More Information
Article History
Received: 13 August 2021
Accepted: 7 December 2021
First Online: 27 January 2022
Declarations
:
: A Weickhardt: research funding: MSD, Pfizer, Novartis, and BMS. Travel funding: MSD. Honoraria: MSD and BMS. Advisory board: MSD, BMS, and Merck. M Perera Marlon Perera is sponsored by the Australian-America Fulbright Commission administered through a 2021–2022 Fulbright Future Scholarship funded by The Kinghorn Foundation.
: Not applicable.
: Not applicable.
